Edgestream Partners’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.8M	Buy	+342,923	New	+$4.8M	0.13%	306
2024 Q2	–	Sell	-112,118	Closed	-$2.3M	–	890
2024 Q1	$2.3M	Buy	+112,118	New	+$2.3M	0.11%	304